title: Cost-effectiveness analysis: sleeping with an enemy or a friend?
authors.forename: S C
authors.initials: SC
authors.lastname: Gulati
authors.forename: J D
authors.initials: JD
authors.lastname: Bitran
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000191:economics; D002945:Cisplatin / Q000008:administration & dosage; D003362:Cost-Benefit Analysis; D004345:Drug Industry; D005249:Fees and Charges; D017048:Health Care Costs; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000191:economics; D012109:Research Support as Topic; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014751:Vindesine / Q000008:administration & dosage; D000077235:Vinorelbine
chemical_list: D014747:Vinblastine; D002945:Cisplatin; D000077235:Vinorelbine; D014751:Vindesine